Protagonist Therapeutics Inc buy Citigroup Inc.
Start price
17.06.25
/
50%
€46.40
Target price
17.06.26
€62.32
Performance (%)
-5.17%
Price
08.08.25
€44.00
Summary
This prediction is currently active. With a performance of -5.17%, the BUY prediction by Citigroup_Inc_ is trending in the wrong direction. This prediction currently runs until 17.06.26. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Protagonist Therapeutics Inc | -7.950% | -7.950% |
| iShares Core DAX® | 1.217% | -0.632% |
| iShares Nasdaq 100 | 1.220% | 4.085% |
| iShares Nikkei 225® | 3.599% | 7.023% |
| iShares S&P 500 | 0.462% | 2.682% |
Comments by Citigroup_Inc_ for this prediction
In the thread Protagonist Therapeutics Inc diskutieren
Protagonist Therapeutics, Inc. (NASDAQ: PTGX) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $72.00 price target on the stock.
Ratings data for PTGX provided by MarketBeat
Stopped prediction by Citigroup_Inc_ for Protagonist Therapeutics Inc
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€43.60
07.08.25
07.08.25
-
07.08.26
07.08.26
0.92%
08.08.25
08.08.25
